Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder
NCT00374920
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Bipolar Disorder With Manic or Mixed Episodes
Interventions
DRUG:
MEM 1003
Sponsor
Memory Pharmaceuticals
Collaborators
[object Object]